Cancer Research UK launches an international study to answer the final questions before aspirin could be recommended to reduce cancer risk. Studies have estimated that widespread use of low-dose aspirin could lead to a 10% drop in the number of people dying from some cancers, but for every 17 lives saved by preventing cancer or heart attacks there would be 2 deaths* caused by strokes, bleeding or ulcers. While research has shown that taking aspirin for 10 years would have benefits for most people between the ages of 50 and…
Read More